Obsidian Therapeutics annual revenue
2024
2025
Obsidian Therapeutics reported $1,986 in revenue for fiscal 2025, an increase of 6306.45% from the previous fiscal year.
View full Obsidian Therapeutics company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1,986 | $1,955 | +6306.45% |
| 2024 | 2024-12-31 | $31 | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
Obsidian Therapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Obsidian Therapeutics source filings ↗